CAR T-cell immunotherapy, SEM

CAR T-cell immunotherapy, SEM

C038/9285

Rights Managed

Caption

T-cells and lymphoma cancer cell. Composite coloured scanning electron micrograph (SEM) of T-cells (purple) and a lymphoma cancer cell (pink). T-cells are a component of the body's immune system. Chimeric antigen receptor (CAR) T-cell therapy takes T-cells from a patient's bloodstream and reprograms them to recognize a specific protein found on lymphoma cells. The T-cells are reintroduced to the patient's blood system where the find and attack the lymphoma cells. Early trials indicate that CAR T-cell therapy is effective for the treatment of lymphoma in patients with no other good treatment options. Magnification: x9000 when printed at 10 centimetres high.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}